Environmental insult, disease or trauma can affect the physical integrity of neuronal circuits, and the inability of many neurons to regenerate injured axons invariably leads to irreversible neural dysfunction [1] . The conserved second messenger cyclic adenosine monophosphate (cAMP) can promote axonal re-growth [2] [3] [4] [5] . Widely used pharmacological or genetic approaches to increase intracellular levels of cAMP are often inadequate for precise neural-circuit reconstruction because their activity cannot be easily timed to specifi c target cells. These shortcomings have prevented the controlled repair of pre-defi ned neurons at selected time points in whole specimens. Thus, technologies to guide neuronal repair in time and space would enable studies of neural-circuit recovery with unprecedented resolution. Towards this aim, we have implemented a proofof-principle optogenetic method to promote the selective regeneration of refractory axons in a living vertebrate.
Our approach is based on the bluelight activatable adenylyl cyclase bPAC from the soil bacterium Beggiatoa [6] . As an experimental paradigm we used the afferent neurons of the zebrafi sh lateral line, which have one central axon that projects along the hindbrain, and one peripheral axon that innervates superfi cial mechanosensory receptors called neuromasts ( Figures  1A,B and S1A-C in Supplemental Information, published with this article online). Transgenes can be specifi cally expressed in lateralis neurons using the 'SILL' enhancer, either in single neurons by plasmid injection or in the entire neuronal population from chromosomeintegrated DNA [7] ( Figure S1D ). Using SILL, we generated zebrafi sh expressing a bPAC-Myc-V2A-mCherry fusion gene (hereafter bPAC-mCherry) alone or together with the presynaptic marker Synapsin1-GFP [8] ( Figure  S1H -J). Control fi sh co-expressed Synapsin1-GFP and membranetargeted mCherry (Figure S1E-G). bPAC-mCherry expression did not affect the development, synaptogenesis, or stability of these neurons ( Figure  S1K -M). To promote neuronal damage at selected locations and probe repair in living zebrafi sh larvae, we employed a nanosecond ultraviolet laser to cut the entire lateralis nerve using the stable transgenic line Tg [HGn39D], or individually identifi ed axons in fi sh with mosaic expression of mCherry ( Figures  1C-N ,P-R and S2A-F) [7] . All types of cuts led to a rapid distal degeneration ( Figures 1D,G ,J,M and S2A-F). Postinjury quantifi cations showed that nearly 100% of the severed peripheral axons regenerated and re-innervated neuromasts within 72 hours ( Figure  1O ). However, only 5% of the central axons regenerated within the same period, regardless of the presence of uncut axons ( Figure 1O ). Although it is currently unknown what prevents lateralis central axons from re-growing, central glia may have an inhibitory effect. These results indicate that similarly to many mammalian neurons, lateralis afferent neurons regenerate effi ciently their peripheral axons but very poorly their central projections to the brain [1] .
Using ELISA we confi rmed that photostimulation of bPAC-mCherry at 450-490 nm raised cAMP levels in 5-day post-fertilization (dpf) zebrafi sh that resulted from injecting bPACmCherry mRNA into fertilized eggs ( Figure S2G ). Next, we photostimulated neurons expressing mCherry or bPAC-mCherry in 5-dpf fi sh after severing peripheral or central axons. Quantifi cations revealed that the onset and speed of peripheral-axon re-growth did not differ signifi cantly between control and bPAC-mCherry(+) neurons ( Figure S2H-K) . Remarkably, however, the regeneration of severed central axons of bPAC-mCherry(+) neurons dramatically increased after photostimulation ( Figure 1P-T) . We also achieved similar success rates of central-axon regeneration using the Tg[SILL:bPAC-mCherry] stable transgenic line (Figure S2L-Q) . Pharmacological inhibition assays revealed that central-axon regenerative success was dependent on cAMPdependent protein kinase-A [2] ( Figure  1S ). Imaging Synapsin1-GFP expressed in individually identifi ed neurons before severing and after bPAC stimulation showed that regenerated central axons re-targeted the correct area of the brain, and re-formed fewer but mature presynaptic structures (Figure 1U,V) . It will be interesting to test the ability of bPAC to promote the repair of other neurons, including the Mauthner cell [4] . Towards this end, we have generated a stable transgenic line that can express bPAC-V2A-mCherry under control of GAL4 drivers (data not shown).
The biological novelty that arises from these results is that under permissive conditions given by elevation of intracellular cAMP there is no critical period for lateralis-neuron axonogenesis and synaptogenesis. Additionally, our results indicate that individual regenerating axons are able to actively pathfi nd in the absence of scaffolding axons. Yet, the most salient aspect of this work is the demonstration of a simple and versatile optogenetic approach that achieved the desired aim of promoting the regeneration of refractory axons in the whole animal. This strategy is superior to classical pharmacological or genetic methods to increase cAMP levels because of the higher spatiotemporal resolution of light. It is also generally applicable because bPAC-mediated elevation of cAMP works across species and does not need additional factors. In its current implementation, this approach will be immediately suitable to probe the capacity of defi ned neural circuits to reclaim functionality after the timeselected repair of individual or multiple neurons. Its potential may further increase by using adenylyl cyclases sensitive to longer wavelengths for better penetration and lower toxicity. Additionally, adaptation of this method to molecular-screening platforms may help to identify cell-autonomous and non-autonomous effectors of axonal re-growth downstream of cAMP signaling, to fi nd molecules with therapeutic potential [9] . In summary, the control of neuronal repair by optogenetics represents a powerful tool that could fi nd broader uses in neurobiological research and biomedicine.
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